A meta-analysis of safety and efficacy of endovascular aneurysm repair in aneurysm patients with severe angulated infrarenal neck.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 10 07 2021
accepted: 08 02 2022
entrez: 24 2 2022
pubmed: 25 2 2022
medline: 16 3 2022
Statut: epublish

Résumé

A growing number of abdominal aortic aneurysms with severe angulated neck anatomy is treated by endovascular means. However, contradictory early and late outcomes have been reported. Our review and outcome analysis attempted to evaluate the available literature and provide clinicians with a base for clinical implementation and future research. A systematic review of the literature was undertaken to identify the outcomes of endovascular aneurysm repair in patients with severe infrarenal neck angulation (SNA ≥ 60°) vs non-severe neck angulation (NSNA). Outcome measures included perioperative complications, type 1a endoleak, neck-related secondary procedures, stent graft migration, aneurysm rupture, increase (>5mm) in sac diameter, all-cause and aneurysm-related mortality (PROSPERO Nr.: CRD42021233253). Six observational studies reporting on 5981 patients (1457 with SNA and 4524 with NSNA) with a weighted mean follow-up period of 1.8 years were included. EVAR in SNA compared with NSNA was associated with a higher rate of type 1a endoleak at 30 days (4.0% vs 1.8%; p< 0.00001), at 1 year (2.8% vs 1.9%; p<0.03), at 2 years (4.9% vs 2.1%; p< 0.0002), at 3 years (5.6% vs 2.6%; p< 0.0001). The rate of neck-related secondary procedures was significantly higher at 1 year (6.6% vs 3.9%; p<0.05) and at 3 years (13.1% vs 9%; p<0.05). Graft migration, aneurysm sack increase, aneurysm rupture and all-cause mortality were not statistically different at mid-term. The use of EVAR in severely angulated infrarenal aortic necks is associated with a high rate of early and mid-term complications. However, aortic related and all-causes mortality are not higher compared to patients with NSNA. Therefore, EVAR should be cautiously used in patients with SNA.

Identifiants

pubmed: 35202427
doi: 10.1371/journal.pone.0264327
pii: PONE-D-21-22527
pmc: PMC8870420
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0264327

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Ann Vasc Surg. 2019 Oct;60:61-69
pubmed: 31028850
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
J Endovasc Ther. 2007 Feb;14(1):1-11
pubmed: 17291144
J Vasc Surg. 2017 Jul;66(1):45-52
pubmed: 28274751
Vascular. 2020 Dec;28(6):683-691
pubmed: 32408856
Eur J Vasc Endovasc Surg. 2019 Jan;57(1):8-93
pubmed: 30528142
J Vasc Surg Cases Innov Tech. 2019 Jun 29;5(3):319-322
pubmed: 31334409
J Endovasc Ther. 2018 Dec;25(6):726-734
pubmed: 30280649
J Vasc Surg. 2020 Jun;71(6):1881-1889
pubmed: 31690524
J Vasc Surg. 2013 Feb;57(2):527-38
pubmed: 23265584
J Vasc Surg. 2018 Dec;68(6):1725-1735
pubmed: 29914837
J Vasc Surg. 2002 May;35(5):1048-60
pubmed: 12021727
J Vasc Surg. 2018 Jun;67(6):1699-1707
pubmed: 29248241
J Endovasc Ther. 2014 Dec;21(6):841-7
pubmed: 25453888
Ann Vasc Surg. 2020 Jan;62:173-182
pubmed: 31394211
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
J Vasc Surg. 2014 Jun;59(6):1495-501, 1501.e1
pubmed: 24507824
Cardiovasc Intervent Radiol. 2016 May;39(5):668-675
pubmed: 26634739
J Vasc Surg. 2014 Oct;60(4):885-92.e2
pubmed: 25088739
J Vasc Surg. 2015 Jan;61(1):28-34
pubmed: 25153490
Semin Vasc Surg. 2012 Dec;25(4):182-6
pubmed: 23206563
J Endovasc Ther. 2009 Oct;16(5):567-76
pubmed: 19842737
Cardiovasc Intervent Radiol. 2020 Jul;43(7):971-980
pubmed: 32385611
Expert Rev Med Devices. 2021 Mar;18(3):281-290
pubmed: 33618596
Eur J Vasc Endovasc Surg. 2019 Aug;58(2):175-181
pubmed: 31235305
J Cardiovasc Surg (Torino). 2020 Feb;61(1):60-66
pubmed: 29327561
Vascular. 2010 Mar-Apr;18(2):93-101
pubmed: 20338133
J Vasc Surg. 2017 Jun;65(6):1598-1607
pubmed: 28190716
J Vasc Surg. 2011 Sep;54(3):616-27
pubmed: 21802890
Ann Vasc Surg. 2011 Nov;25(8):1012-9
pubmed: 22023937
J Endovasc Ther. 2019 Jun;26(3):350-358
pubmed: 30900510

Auteurs

Giulia Bernardini (G)

Department of Vascular Surgery and Organ Transplant Unit, University Hospital of Catania, Catania, Italy.

Sarah Litterscheid (S)

Institute for Vascular Research, St Franziskus Hospital, Münster, Germany.

Giovanni Battista Torsello (GB)

Institute for Vascular Research, St Franziskus Hospital, Münster, Germany.

Giovanni Federico Torsello (GF)

Department of Diagnostic and Interventional Radiology, Charité University Medicine, Berlin, Germany.

Efthymios Beropoulis (E)

Institute for Vascular Research, St Franziskus Hospital, Münster, Germany.

Denise Özdemir-van Brunschot (D)

Department of Vascular and Endovascular Therapy, Augusta Hospital and Catholic Hospital Group, Düsseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH